title: Combination antiretroviral therapy and indoleamine 2,3-dioxygenase in HIV infections: challenges and new opportunities.
authors.affiliation: aLaboratory of Innate Immunity, Centre Hospitalier Universitaire (CHU) Staine-Justine Research Center bDepartment of Microbiology, Infectiology and Immunology cCentre Hospitalier Universite de Montreal (CHUM) dUniversity of Montreal eMcGill University Health Center, McGill University fDepartment of Biological Sciences, University of Quebec at Montreal (UQAM), Montreal, Quebec, Canada.
authors.forename: Ali
authors.initials: A
authors.lastname: Ahmad
authors.forename: Vikram
authors.initials: V
authors.lastname: Mehraj
authors.forename: Mohammad-Ali
authors.initials: MA
authors.lastname: Jenabian
authors.forename: Suzanne
authors.initials: S
authors.lastname: Samarani
authors.forename: Cecile
authors.initials: C
authors.lastname: Tremblay
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Routy
mesh_terms: D015658:HIV Infections; D006801:Humans; D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D007371:Interferon-gamma
chemical_list: D050503:Indoleamine-Pyrrole 2,3,-Dioxygenase; D007371:Interferon-gamma